Synopsis : ViiV Healthcare’s HIV treatment Cabenuva has been approved by the U.S. Food and Drug Administration for use every two months,…
Agrochemicals
-
-
Synopsis :: -ImmunityBio shared positive results from the clinical trial of its IL-15 superagonist Anktiva (N-803) to treat people living with human…
-
AgrochemicalsGlobal Market
Embark Announces Appointment of Stephen Houghton as Chief Operating Officer
by adminby adminSynopsis : Autonomous vehicle industry veteran will build on early success to lead operational growth, oversee geographic expansion, and spearhead Embark’s commercialization…
-
AgrochemicalsMadrigal Pharmaceuticals
Dominic F. Labriola Joins Madrigal Pharmaceuticals as Chief Data and Analytics Officer
by adminby adminSynopsis : Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for fatty liver diseases, announced today that Dr. Dominic F.…
-
AgrochemicalsGlobal Market
Biogen Departure Train Chugs on as Two Board Members Exit
by adminby adminSummary : One week after Johnna Rossell departed Biogen for Enzyvant, the embattled company announced that two members of its board of…
-
AgrochemicalsCovid Drugs
Merck’s COVID-19 pill active against Omicron in lab studies
by adminby adminSummary : Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir…
-
Synopsis : Granules India Ltd on Thursday said it has received approval from the US health regulator for its generic Amphetamine mixed…
-
Agro Science & ResearchAgrochemicals
String Bio Shows How Methane can be converted into Biostimulants for Crops
by adminby adminSummary : String Bio, a Bengaluru-based company, has developed a platform for converting methane into various solutions such as biostimulants for crops,…
-
AgrochemicalsGlobal Market
Interpace Biosciences Terminates Rights Offering Announces Change in CMS Medicare Reimbursement of its Thyroid Tests
by adminby adminSummary : Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”) a leader in enabling personalized medicine, announced today that it was…
-
AgrochemicalsGlobal Market
Biogen Recoups Much-Needed $2.3B with Sale of Samsung Bioepis Stake
by adminby adminSynopsis : Biogen is selling its nearly 50% stake in South Korea-based Samsung Bioepis for $2.3 billion. The move will provide Biogen…
